Endo International | Srodki Pieniężne I Ekwiwalent



Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.63B 838M 2025-09
Amarin USD 122.8M 25.08M 2025-09
ANI Pharmaceuticals USD 262.61M 44.81M 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Coherus Biosciences USD 103.35M 113.54M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Hikma Pharmaceutical USD 236M 48M 2025-06
Ligand Pharmaceuticals USD 664.52M 596.85M 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pacira USD 147.59M 152.89M 2025-09
Perrigo USD 432.1M 22.1M 2025-09
Pfizer USD 1.34B 295M 2025-09
Phibro Animal Health USD 55.49M 17.28M 2025-12
Supernus Pharmaceuticals USD 151.37M 6.66M 2025-09
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xeris Pharmaceuticals USD 91.6M 32.32M 2025-09
Zoetis USD 2.08B 649M 2025-09


Endo International Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.